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Background: A review of the literature and an extensive Medline search revealed that this is 
the first case report of the use of guaifenesin to increase sperm motility.
Case: A 32-year-old male presented for an infertility evaluation. He reported an inability 
to conceive with his wife after 18 months of unprotected intercourse. A semen analysis was 
performed that included spermatozoa count, liquefaction, morphology, motility, viscosity and 
volume. Initial results of the semen analysis demonstrated low sperm count and motility. The 
provider offered treatment with guaifenesin 600 mg extended release tablets twice daily. Two 
months after guaifenesin therapy the semen analysis was repeated that demonstrated marked 
improvement in both total sperm count and motility.
Conclusion: Evidence for the effectiveness of guaifenesin is almost entirely anecdotal. Given 
the mechanism of action of guaifenesin, it is not clear from this case why the patient demon-
strated such a large improvement in both sperm count and motility. Additional studies of the 
effects of guaifenesin on male fertility could yield information of the medication’s effect on 
men with normal or decreased total sperm counts.
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Background
There are currently anecdotal reports and popular news media stories on the use of 
guaifenesin, particularly the brand name product Robitussin® (Pfizer, Inc., New York, 
NY), for use in treating both male and female infertility.1–4 Guaifenesin is an expectorant 
medication sold over the counter and usually taken by mouth to assist expectoration 
of phlegm from the airways in acute respiratory tract infections. Its mode of action in 
treating infertility is not well understood, but it appears to decrease mucus viscosity. 5 
The case presented here discusses the use of guaifenesin in improving male fertility.
Case
A 32-year-old male patient presented to his primary care provider for an infertility 
evaluation. The patient is a nonsmoker, who consumes little or no alcohol with no 
known allergies. A recent screening exam for pulmonary tuberculosis was negative 
and the patient had recently undergone a required military service physical exam.
He reported an inability to conceive with his wife after 18 months of unprotected, 
regular intercourse. As part of a routine infertility evaluation a semen analysis was 
performed that included spermatozoa count, liquefaction, morphology, motility, viscos-
ity and volume (CPT Code 89320). Initial results of the semen analysis demonstrated 
low sperm count and motility (Table 1). This sample, as well as the follow-up sample, International Journal of General Medicine
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were obtained through masturbation and provided to the lab 
within 30 minutes of collection.
The patient’s primary care provider offered treatment 
with guaifenesin 600 mg extended release tablets twice daily. 
The semen analysis was repeated 2 months after initiation of 
guaifenesin therapy. The repeat semen analysis demonstrated 
marked improvement in both total sperm count and motility 
(Table 1). The patient made no other significant lifestyle 
changes during the treatment course with guaifenesin. 
At the time of writing, however, the patient’s wife had not 
yet conceived a child.
Conclusion
This case report describes the semen analysis laboratory 
results in a male patient who was given guaifenesin. Guaife-
nesin is a mucolytic agent usually taken orally to assist the 
expectoration of phlegm from the airways in acute respira-
tory tract infections. Guaifenesin is a safe medication that is 
available over the counter. Its use may improve both male 
and female infertility related to mucus production. Scien-
tific evidence for the effectiveness of guaifenesin is almost 
entirely anecdotal; a review of medical literature revealed 
very limited data on use of guaifenesin for infertility.5,6 There 
appeared to be some improvement in a small study without 
controls of female infertility related to hostile cervical 
mucus.5 Check regards guaifenesin as the simplest but least 
effective method of improving cervical mucus.7 Given the 
proposed mechanism of action of guaifenesin, it is not clear 
from this case why the patient demonstrated such a large 
improvement in both sperm count and motility. Additional 
study of the effects of guaifenesin on male fertility suggests 
the need to conduct a more rigorous placebo-controlled 
clinical trial that could yield information of the medica-
tion’s effects on men with normal or decreased total sperm   
counts.
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Table 1 semen analysis laboratory results
Lab result January 6, 2009 March 3, 2009
Motility 10% 61%
sperm count (million/mL) 2.4 34.7
Viscosity Normal Normal
Volume (mL) 4.0 4.0
Days of abstinence 4 3